Actual strategies for neuroprotement in glaucoma

Time codes:
  • 01:15

    The purpose of the treatment of glaucoma

  • 02:29

    The need for neuroprotement

  • 03:10

    Approaches to neuroprotection

  • 04:06

    The use of retinolamine

  • 06:11

    Laser transconde -junkoagulation method

  • 10:10

    The method of indirect retinoprotection

  • 12:00

    Study of Mexidol® in patients with I-III soup

  • 13:20

    The maximum positive effect during a dosage of 300 mg per day

  • 15:26

    The effectiveness of the drug Mexidol® at the III stage of the disease

  • 16:28

    Course therapy Mexidol® and Mexidol® Forte

  • 17:32

    Clinical recommendations

Egorov Evgeny Alekseevich - MD, professor, president of the Russian glaucomal society, head. Department of ophthalmology named after Academician A.P. Nesterova Rnim them. N.I. Pirogov

Announcement:

The main goal of the treatment of glaucoma is to preserve visual functions and quality of life of the patient with an adequate cost of treatment. Neuroprotection is a very important aspect in preserving visual functions in patients with glaucoma. The studies have demonstrated the results of the effectiveness and safety of the drug Mexidol® in patients with primary open-angle glaucoma of the I-III stage.

Block of articles on this topic

The effect of antioxidant therapy on some pathogenetic factors of primary open -angle glaucoma

Authors:
T.N. Malishevskaya 1 , Yu.E. Filippova 2

1 FSBI "National Medical Research Center of Eye Diseases named after Helmholtz »Ministry of Health of Russia, Moscow, Russia;
2 GAUZ “Regional Ophthalmological Dispensary”, Tyumen, Russia

Mexidol in the complex treatment of glaucoma

Author:
E.A. Egorov, N.G. Davydova, I.A. Romanenko, N.D. Novikova

RNIMU named after N.I. Pirogov, GB of GB named after Helmholtz, Moscow

The possibilities and results of the use of antioxidant therapy in ophthalmological practice

Authors:
A.B. Movsisyan 1.2 , J.G. Oganezova 2.3 , E.A. Egorov 2

1 GBUZ “Hospital for Wars of Wars No. 2 DZM”, Moscow, Russia;
2 FGAOU in Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia;
3 FGBNU "Medical and Genetical Scientific Center named after Acad. N.P. Bochkova ", Moscow, Russia

The experience of neuroprotective therapy of primary open -angle glaucoma based on the use of various forms of Mexidol

Authors:
E.S. Leonova 1.2 , S.V. Polyakov 1.2 , M.A. Pozdnyakova 2 , E.P. Yarygina 3 , S.O. Semisinov 2

1 NUZ "Road Clinical Hospital at the Gorky station OJSC" Russian Railways ", the interdorrutal center of ophthalmology
2 GBOU VPO" Nizhny Novgorod State Medical Academy "
3 GBUZ but" City Hospital No. 35 ", City Glacks Center

The use of Mexidol in the treatment of primary open -angle glaucoma

Authors:
I.A. Loskutov, O.M. Andryukhina, A.A. Kovrizhkina

Moscow Regional Research Clinical Institute. M.F. Vladimir

Information is intended for medical and pharmaceutical workers. This information cannot serve as a replacement for a doctor’s consultation.

Source of photos and images Shutterstock.com